Figure 1. CSB does not affect the recruitment of OGG1 to oxidative DNA damage. (A) Representative stills of time-lapse ... Figure 1. CSB does not affect.

Slides:



Advertisements
Similar presentations
Figure 1. drb7.2 mutant plants display altered accumulation of endoIR-siRNA. Wild-type (Col-0) and drb7.2 mutant plants were subjected to high throughput.
Advertisements

Figure 1. PARP1 binds to abasic sites and DNA ends as a monomer
Figure 1. The flow chart illustrates the construction process of anti-CRISPRdb, and the information that users can obtain from anti-CRISPRdb. From: Anti-CRISPRdb:
Figure 1: Necrobiosis lipoidica: Yellow-brown skin lesions with indurated borders located on both lower legs. Figure 1: Necrobiosis lipoidica: Yellow-brown.
Figure 1. (A) The VEGF promoter PQS and scheme of G oxidation to OG, as well as (B) the proposed APE1-dependent pathway ... Figure 1. (A) The VEGF promoter.
Figure 1. A CRISPR/Cas9 synthetic lethal screen with PRMT5 inhibitor EPZ in H2171 cell line. (A) A pie chart ... Figure 1. A CRISPR/Cas9 synthetic.
Figure 1. Sgs1 binds to RPA-coated ssDNA
Figure 1. Circular taxonomy tree based on the species that were sequenced in our study. Unless provided in the caption above, the following copyright applies.
Figure 1. Overview of the workflow of NetworkAnalyst 3.0.
Figure 7. Primary cells from prostate tumours are more sensitive to ML than adjacent non-cancerous cells from the ... Figure 7. Primary cells from.
Figure 1: Axial T2 W images of penis showed a well-defined septated area of 2 cm in the posterior aspect of ... Figure 1: Axial T2 W images.
Figure 1. Effect of random T/A→dU/A substitutions on transcription by T7 RNAP using a 321 bp DNA transcription template ... Figure 1. Effect of random.
FIGURE 1 Histological diagnoses divided into 8-year time frames (n = 1208). Unless provided in the caption above, the following copyright applies to the.
FIGURE 1 The effect of daprodustat on hemoglobin (Hgb) levels
Figure 6. HU sensitivity is due to the failure to process multiple consecutive ribonucleotides. 10-fold serial ... Figure 6. HU sensitivity is due to the.
Figure 1. BRCA1-associated R-Loop accumulation at a non-coding region upstream of ESR1 locus. (A) Alignment of DRIP-seq ... Figure 1. BRCA1-associated.
FIGURE 2 Responses to the question: regarding vasoactive drugs, does your centre use the following frequently, rarely ... FIGURE 2 Responses to the question:
FIGURE 1 Maternal (A) urinary aldosterone; (B) plasma active renin; (C) urinary AGT concentrations; and (D) plasma AGT ... FIGURE 1 Maternal (A) urinary.
Figure 1. Ratios of observed to expected numbers of exon boundaries aligning to boundaries of domain and disorder ... Figure 1. Ratios of observed to expected.
Fig. 1 Kaplan-Meier plot of cumulative incidence of cancer onset following dermatomyositis diagnosis stratified ... Anti-TIF1-Ab: anti-transcriptional.
Figure 1. Chemical structures of DNA and tc-DNA
Fig. 1 Mean change from baseline in ANC ± s. e
Point estimates with ... Point estimates with 95% CI. HR: hip replacement; KR: knee replacement. Unless provided in the caption above, the following copyright.
FIGURE 1 Participant flow diagram. Exercise Counseling Clinic (ECC).
Graph 1. The number of homicide cases per year discussing neuro-evidence. Unless provided in the caption above, the following copyright applies to the.
Figure 6. The DNA lyase activity of hNTHL1 contributes to the processing of lesions in nucleosomes, even in the ... Figure 6. The DNA lyase activity of.
Figure 1. Analysis of human TRIM5α protein with Blast-Search and PhyML+SMS ‘One click’ workflow. (A) NGPhylogeny.fr ... Figure 1. Analysis of human TRIM5α.
Figure 2. Natural history of chlamydia transmission, with arrows showing the transitions between health states. Figure 2. Natural history of chlamydia.
Figure 1 Nelson-Aalen estimates of the cumulative incidence rates for patients on versus off IST. ON = optic neuritis; ... Figure 1 Nelson-Aalen estimates.
FIGURE 1 Study consort diagram
Fig. 2 Case 2. Levels of serum creatinine and anti-GBM antibodies before and during treatment with cyclophosphamide, ... Fig. 2 Case 2. Levels of serum.
Figure 1. Illustration of DGR systems and their prediction using myDGR
Figure 1. The pipeline of Aggrescan3D 2.0 server.
Figure 1. EBOV VP35 has NTP-binding and NTPase activities
Figure 1. Prediction result for birch pollen allergen Bet v 1 (PDB: 1bv1), as obtained by comparison to the cherry ... Figure 1. Prediction result for.
Figure 1. Using Voronoi tessellation to define contacts
Figure 1. Designed cotranscriptional RNA structures
Figure 1. Analysis of the AP lyase activity of BsuLigD
Figure 4. RLS spectra of (A) TMPipEOPP and (B) OMHEPzEOPP in the presence of different concentrations of KRAS. The RLS ... Figure 4. RLS spectra of (A)
Figure 1. PaintOmics 3 workflow diagram
Figure 1. Schematic diagram of solar energy and coal-fired power generation system. Unless provided in the caption above, the following copyright applies.
Figure 1. Uncertainty reduction, value creation, and appropriation in two case studies. Unless provided in the caption above, the following copyright applies.
Figure 1. (A) Architecture of Doc2Hpo. (B) Interactive user interface
Figure 1. MERMAID web server interface (Start page, Parameter page): MERMAID provides two ways to submit a protein ... Figure 1. MERMAID web server interface.
Figure 1. Yvis platform overview
Figure 1. The framework of NetGO with seven steps
Figure 1. Workflow of the HawkDock server that is divided into three major steps: (i) input of unbound or bound protein ... Figure 1. Workflow of the HawkDock.
Figure 1. Overview of features that can be assessed in a single RegulationSpotter VCF analysis run. Depending upon a ... Figure 1. Overview of features.
Figure 1 Patient disposition
Figure 1. Accumulation kinetics of TC-NER factors reveal a CSA independent UVSSA recruitment. (A) Representative images ... Figure 1. Accumulation kinetics.
Figure 2. Result page of a Primer3Plus Cloning run showing the left and right primers in blue and yellow. The included ... Figure 2. Result page of a Primer3Plus.
Figure 1. Workflow of the analysis to estimate the number of true human miRNAs. Samples containing NGS data were ... Figure 1. Workflow of the analysis.
Fig. 1. —Synteny analysis of melon chromosome 1 (brown) and cucumber chromosome 7 (green) based on melon-cucumber ... Fig. 1. —Synteny analysis of melon.
Figure 1. Scheme of a phosphorothioated-terminal hairpin formation and self-priming extension (PS-THSP) for selection ... Figure 1. Scheme of a phosphorothioated-terminal.
Figure 1. 3C analysis of HEM3, BLM10, and SEN1 genes in rpb4Δ and isogenic wild type cells. (A) Schematic ... Figure 1. 3C analysis of HEM3, BLM10, and.
Figure 1 Genetic results. No case had more than one diagnostic result
Figure 1. (A) Baseline contrast-enhanced CT scan of melanoma patient presenting with metastases in the liver and lymph ... Figure 1. (A) Baseline contrast-enhanced.
Figure 1. Prevalence of parasitic infection and anemia among the children. Unless provided in the caption above, the following copyright applies to the.
Figure 1. The overlap between Ensembl/GENCODE, RefSeq and UniProtKB genes. The number of genes classified as coding in ... Figure 1. The overlap between.
Fig. 1. —OR gene tree including 2,973 genes from seven ants, honeybee, and jewel wasp. The tree was reconstructed ... Fig. 1. —OR gene tree including 2,973.
Figure 1. DNA-guided RNA cleavage activity
Figure 1. GWAS Catalog associations for coronary artery disease plotted across all chromosomes. Associations added ... Figure 1. GWAS Catalog associations.
Figure 1 The workflow of CAR development from a hybridoma
Figure 1. Crystal structures of Rim1
Source:Zimnisky (2014). Source:Zimnisky (2014).
Figure 1 Mechanisms of mitral regurgitation.
Figure 1. Removal of the 2B subdomain activates Rep monomer unwinding
Figure 5. The endonucleolytic product from PfuPCNA/MR activity is displaced from dsDNA. Results from real-time ... Figure 5. The endonucleolytic product.
Figure 4. In vitro mo5U forming activity of TrmR
Figure 1. (A) Overview of ENPD including data source, data processing and features. Transcriptomes from TSA, genomes ... Figure 1. (A) Overview of ENPD.
Presentation transcript:

Figure 1. CSB does not affect the recruitment of OGG1 to oxidative DNA damage. (A) Representative stills of time-lapse ... Figure 1. CSB does not affect the recruitment of OGG1 to oxidative DNA damage. (A) Representative stills of time-lapse imaging to determine accumulation kinetics of OGG1-GFP in CSB-proficient (upper panel) or CSB-deficient (lower panel) MRC-5 cells at micro-irradiated (405 nm) subnuclear regions, indicated by arrows, in the presence of 10 μM Ro 19-8022 photosensitizer. Scale bar: 7.5 μm. (B) Accumulation kinetics of OGG1-GFP at micro-irradiated areas (as shown in A). The mean relative fluorescence intensity is plotted against time in seconds. (C) FRAP analysis of OGG1-GFP expressed in CSB-proficient and deficient MRC-5 cells at locally damaged areas (on damage) or at a similar sized area without DNA damage (no damage). For (B) and (C), error bars indicate the SEM of 20 cells of 2 independent, pooled experiments. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Nucleic Acids Res, Volume 46, Issue 15, 28 June 2018, Pages 7747–7756, https://doi.org/10.1093/nar/gky579 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 2. CSB facilitates recruitment of XRCC1 to BER-induced single strand breaks. (A) Representative stills of ... Figure 2. CSB facilitates recruitment of XRCC1 to BER-induced single strand breaks. (A) Representative stills of time-lapse imaging to determine accumulation kinetics of XRCC1-YFP in CSB-proficient or CSB-deficient MRC-5 cells on direct SSBs (405 nm laser micro-irradiated regions, indicated by arrows) in the absence (upper two panels) or presence of 15 μM PJ-34 to inhibit PARPs (lower two panels). (B) Accumulation kinetics of XRCC1-YFP at micro-irradiated areas (as shown in A). The mean relative fluorescence intensity is plotted against time in seconds. (C) Representative stills of time-lapse imaging to determine accumulation kinetics of XRCC1-YFP in CSB-proficient (upper panel) or CSB-deficient (lower panel) MRC-5 cells on BER induced SSBs cells at micro-irradiated (405 nm laser) subnuclear regions, indicated by arrows, in the presence of 10 μM Ro 19-8022 photosensitizer and 15 μM PJ-34. (D) Accumulation kinetics of XRCC1-YFP on BER induced SSBs (as shown in C). The mean relative fluorescence intensity is plotted against time in seconds. (E) Representative stills of time-lapse imaging to determine accumulation kinetics of the XRCC1<sup>L360D</sup>-YFP mutant in CSB-proficient (upper panel) or CSB-deficient (lower panel) MRC-5 cells at micro-irradiated (405 nm laser) subnuclear regions, indicated by arrows. (F) Accumulation kinetics of the XRCC1<sup>L360D</sup>-YFP mutant at micro-irradiated areas (as shown in E). The mean relative fluorescence intensity is plotted against time in seconds. (G) Representative stills of time-lapse imaging to determine accumulation kinetics of the XRCC1<sup>L360D</sup>-YFP mutant in CSB-proficient (upper panel) or CSB-deficient (lower panel) MRC-5 cells at micro-irradiated (405 nm laser) subnuclear regions, indicated by arrows, in the presence of 10 μM Ro 19-8022 photosensitizer. (H) Accumulation kinetics of the XRCC1<sup>L360D</sup>-YFP mutant at micro-irradiated areas (as shown in G). The mean relative fluorescence intensity is plotted against time in seconds. For (A, C, E and F), scale bar: 7.5 μm. For (B, D, F and H), error bars indicate the SEM of 20 cells of two independent, pooled experiments. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Nucleic Acids Res, Volume 46, Issue 15, 28 June 2018, Pages 7747–7756, https://doi.org/10.1093/nar/gky579 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 3. XRCC1 binding to BER induced breaks is sensitive to inhibition of transcription. (A) Representative stills of ... Figure 3. XRCC1 binding to BER induced breaks is sensitive to inhibition of transcription. (A) Representative stills of time-lapse imaging to determine accumulation kinetics of XRCC1<sup>L360D</sup>-YFP in untreated (upper panel) or transcription inhibited (DRB, 100 μM) MRC-5 cells at micro-irradiated (405 nm laser) subnuclear regions, indicated by arrows, in the presence of 10 μM Ro 19-8022 photosensitizer. Scale bar: 7.5 μm. (B) Accumulation kinetics of XRCC1<sup>L360D</sup>-YFP at micro-irradiated areas (as shown in A). The mean relative fluorescence intensity is plotted against time in seconds. Error bars indicate the SEM of 20 cells of 2 independent, pooled experiments. (C) Accumulation kinetics of XRCC1<sup>L360D</sup>-YFP expressed in HeLa cells at micro-irradiated areas in the presence of 5 μM Ro 19-8022 photosensitizer in either untreated cells or in the presence of transcription inhibitor (DRB, 100 μM). (D) Accumulation kinetics of OGG1-dsRed expressed in HeLa cells at micro-irradiated areas in the presence of 5 μM Ro 19-8022 photosensitizer in either untreated cells or in the presence of transcription inhibition (DRB, 100 μM). All graphs are representative for two independent experiments (at least 11 cells) and show the mean relative fluorescence intensity ± SEM. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Nucleic Acids Res, Volume 46, Issue 15, 28 June 2018, Pages 7747–7756, https://doi.org/10.1093/nar/gky579 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 4. Proposed model for the CSB function in the repair of oxidative DNA damage. The upper panel represents the ... Figure 4. Proposed model for the CSB function in the repair of oxidative DNA damage. The upper panel represents the classical BER initiation on 8-oxoG lesions (red star) by the concerted action of the OOG1 glycosylase (orange sphere) and APE1 (yellow ball), subsequent recruitment of the XRCC1/LigaseIII complex (blue and red balls, respectively) and DNA Polymerase β (Pol β, dark purple ball) through interaction with the glycosylase further completes repair. The lower panels represent a situation in which an elongating RNA polymerase II complex (RNAPII, purple sphere, direction indicated by curved arrow) runs into a BER-intermediate (e.g. BER-generated SSB) that likely caused inhibition of RNAPII elongation. When CSB (green ball) is present (lower left panel, blue shaded) it will assist in loading the XRCC1/Ligase III (LigIII) complex (blue and red balls, respectively) to stalled RNAPII on BER-intermediates to facilitate the assembly of downstream BER factors, such as DNA Polymerase β (Pol β, dark-purple ball) and stimulate BER progression. In the absence of CSB (lower right panel, orange shaded), BER progression will be limited. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2018. Published by Oxford University Press on behalf of Nucleic Acids Research.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Nucleic Acids Res, Volume 46, Issue 15, 28 June 2018, Pages 7747–7756, https://doi.org/10.1093/nar/gky579 The content of this slide may be subject to copyright: please see the slide notes for details.